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Emerging evidence suggests that combinatorial action of numerous biologically active compounds may be a
valuable source in a variety of therapeutic applications. Several nutraceuticals have demonstrated to augment the
efficacy of pharmacological approaches or provide physiological benefit to improve age-related decline. Recently,
the possibilities of anti-ageing interventions have multiplied also to ameliorate the mitochondrial alterations in
ageing-associated diseases. In this report, we approached a novel treatment strategy by combining two bioactive
dietary constituents (resveratrol and equol) to determine their effect on mitochondrial function. Taking into account
that the biological activities of resveratrol and equol has been observed in a wide range of biological processes,
they were selected to examine whether combining them would be more effective to modulate mitochondrial
function. In HUVEC cells our results demonstrate that the co-administration of these natural products increased
mitochondrial mass and mitochondrial DNA content. Additionally, combined use of both compounds increased
SIRT1 enzymatic activity and induced mitochondrial biogenesis factors such as PGC1-α, TFAM and NRF-1. Therefore,
identification of this novel synergism may provide a new perspective for future treatments aiming to modulate the
mitochondrial activity with implications in maintaining endothelial function which is crucial in the regulation of
immune response. Further studies to discover the molecular details of this crosstalk and to identify new
combinations of active compounds affecting the mitochondrial function will be extremely beneficial to prevent
mitochondrial decline.Background
Ageing process is characterized by a general decline in cel-
lular activity and it is also associated with a decrease in
mitochondrial function correlated to the onset and pro-
gression of age-related pathologies [1]. Mitochondria play
an essential role in ageing and human umbilical vein endo-
thelial cells (HUVEC) have been established as a cellular
model to follow mitochondrial dysfunction during the age-
ing process [2,3]. Consistent with this notion, it is impera-
tive to uncover the molecular mechanisms underlying the
regulation of the decline of mitochondria in order to iden-
tify potential therapeutic targets. Several regulatory factors
are implicated in the modulation of mitochondrial function
[4] and peroxisome proliferator-activated receptor (PPAR)
γ – coactivator-1 (PGC1-α) has emerged as a master* Correspondence: g.scapagnini@gmail.com
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reproduction in any medium, provided the orregulator for the mitochondrial transcription and translation
machinery [5]. Moreover, PGC1-α appears to act as a central
coordinator of multiple transcription factors [6]. In particu-
lar, it has been shown that PGC1-α is able to strongly inter-
act and co-activate the nuclear respiratory factor 1 (NRF-1)
[7]. Furthermore, NRF-1 is implicated in the interaction with
several mitochondrial genes including the mitochondrial
transcription factor A (TFAM), one of the most important
mammalian transcription factors for mitochondrial DNA
(mtDNA) [8]. Noteworthy, recent evidence has highlighted
NAD+-dependent protein deacetylase sirtuin 1 (SIRT1) as a
critical factor for the regulation of mitochondrial function.
Indeed, SIRT1 with PGC1-α and its regulatory circuit have
been recognized to have a direct involvement in the control
of mitochondrial biogenesis and metabolism [9]. Therefore,
PGC1-α constitutes an energy sensing cellular platform that
controls mitochondrial function and its network provides a
link between mitochondria and ageing that may be useful asl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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become a key area in medicine research in order to en-
hance efficiency of treatments and affect not only one single
target, but several targets. Numerous nutraceuticals have
been found to target and attenuate the progression of age-
related dysfunction [10,11]. Currently, there are a variety of
dietary strategies to ameliorate mitochondrial function in
ageing [12]. For instance, among isoflavones (members of
the class of flavonoids) equol (the main active product of
daidzein metabolism) has recently attracted scientific
interest because of its powerful antioxidant activity with
implications in treating age-related diseases [13], however
its influence on mitochondria is still poorly understood.
On the contrary, resveratrol is a naturally occurring
polyphenol with wide-ranging health benefits including
well-established properties in promoting mitochondrial
biogenesis during ageing [14]. The present study aims
to investigate the effects of resveratrol and equol on
mitochondrial biogenesis using the two compounds in-
dividually and in combination.Materials and methods
Cell cultures
HUVEC were obtained from Lonza and maintained in
endothelial basal medium (EBM-2) supplemented with
growth factors (Lonza, Walkersville, MD). Cells were grown
at 37°C in 5% CO2 and serial passages were performed
when the cells reached a 80% confluence. As described by
Grillari et al. [15] at around 30 passages when the cells
exhibited the irreversible growth arrest, they were used for
the experimental procedures. HUVEC cells were treated
with resveratrol (trans-3, 4, 5,-trihydroxystilbene) (pur-
ity 98%) purchased from Cayman Chemical Company
(Ann Arbor, MI) and equol ((3S)-3-(4-Hydroxyphenyl)-
7-chromanol) (purity 98%) purchased from INDOFINE
Chemical Company (Hillsborough, NJ).Figure 1 The combined treatment of resveratrol and equol strongly i
(A) Mitotracker fluorescent intensities were analysed to assess the mitocho
was estimated by qRT-PCR. Representative data of at least 3 experiments e
equol; R: resveratrol; E+R: equol + resveratrol.MitoTracker® Red staining
The HUVEC cells were subdivided into three groups, which
were treated, as previously tested [16], with resveratrol, 10
μM for 48 hours, equol 10 μM [17] for 48 hours, and with
the composition containing resveratrol and equol 10 μM
for 48 hours, respectively. The mitochondrial mass in
HUVEC was determined selectively loading mitochondria
with Mitotracker fluorescent red dye (Invitrogen, Carlsbad,
CA). Fluorescent calcein (green) and Hoechst 33258 (blue)
dyes were used to stain the cytoplasm and the nuclei,
respectively. Optical sections of HUVEC were captured
at ×60-magnification and the mitochondrial density-area
was calculated with respect to cytoplasmatic volume using
Zeiss AxioVision imaging software (Zeiss, Oberkochen,
Germany). Only cells with intact cytoplasmatic calcein
stain were included in the analysis.Quantitative real-time PCR for mitochondrial DNA
Total DNA was extracted from HUVEC cells using the
DirectPCR lysis reagent (Viagen Biotech, Los Angeles, CA).
The number of mtDNA copies was quantified by qRT-PCR
according to the protocols of Adabbo et al. [18]. Two dif-
ferent housekeeping genes were used (cytochrome oxidase
III and β-actin) for normalization. mtDNA per nuclear gen-
ome was calculated as the ratio of cytochrome oxidase III
(mitochondrial) DNA to β-actin (nuclear) DNA. Quantifi-
cation was performed using the ΔΔCT method.SIRT1 activity assay
Nuclear SIRT1 activity was evaluated in cells treated with
resveratrol, equol and resveratrol + equol as described pre-
viously by Ferrara et al. [19]. We measured SIRT1 using a
deacetylase fluorometric assay kit (Sir2 Assay Kit, CycLex,
Ina, Nagano, Japan). The final reaction mixture (100 μL)
contained 50 mM Tris–HCl (pH 8.8), 4 mM MgCl2, 0.5
mM DTT, 0.25 mA/mL Lysyl endopeptidase, 1 μMncreased the number of mitochondria in HUVEC cells.
ndrial biogenesis. (B) Relative mitochondrial DNA (mtDNA) content
ach performed in triplicate. (*= P < 0.05, **= P < 0.01). C: control; E:
Figure 2 Increase of SIRT1 enzymatic activity by combined
administration of resveratrol and equol. Fluorimetric SIRT1
activity assay to determine the effect achieved in HUVEC by the
combined exposure to equol and resveratrol. Representative data
of at least 3 experiments each performed in triplicate. (*= P < 0.05,
**= P < 0.01). AFU: arbitrary fluorescence units; C: control; E: equol;
R: resveratrol; E+R: equol + resveratrol.
Figure 3 Effect of resveratrol and equol on mRNA expression
of PGC1-α (A), NRF-1 (B), TFAM (C) in HUVEC. qRT-PCR
measurement to assess the mRNA expression of the mitochondrial
biogenesis factors. Representative data of at least 3 experiments
each performed in triplicate. (*= P < 0.05, **= P < 0.01). C: control;
E: equol; R: resveratrol; E+R: equol + resveratrol.
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sample. All determinations were performed in triplicate.
Measuring the mRNA expression of mitochondrial
biogenesis factors via qRT-PCR
The qRT-PCR technique was used to determine the effect
of resveratrol, equol and of the mixture of the two com-
pounds (resveratrol + equol) (10 μM for 24 h) on mRNA
expression of mitochondrial biogenesis factors such as Nrf-
1, TFAM and PGC1-α in HUVEC cells using Light Cycler
technology (Roche Molecular Biochemicals, Mannheim,
Germany). The total RNA was isolated with Mini RNA iso-
lation II Kit (Zymo Research, Orange, CA) and was reverse
transcribed using SuperScript III RNase H-free reverse
transcriptase (Invitrogen, Carlsbad, CA). Efficiency of the
PCR reaction was determined performing dilution series of
a standard sample. The housekeeping gene hypoxanthine
phosphoribosyltransferase (HPRT) was used for internal
normalization and quantification was performed using
ΔΔCT method.
Statistical analysis
Differences between various treatments were analysed by
unpaired Student’s t-tests with P values <0.01 considered
highly significant and P < 0.05 considered significant.
Results and discusssion
Combination of resveratrol and equol induces
mitochondrial biogenesis in endothelial cells
In the current study, we examined the combined treat-
ment of resveratrol and equol on HUVEC cells to identify
their effects on the mitochondrial biogenesis. In particular,the primary goal of this investigation was to determine
whether combining resveratrol and equol would increase
the expression of key factors involved in mitochondrial
biogenesis. Several studies were conducted showing the
synergistic effect of resveratrol with different compounds
[20] but the combination with equol has never been tested
on the mitochondrial function. The Mitotracker staining
showed that mitochondria were located in the perinuclear
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veratrol increased significantly the density-area ratio in
Mitotracker-labeled endothelial cells as compared to the
cytoplasmatic volume (Figure 1A).
Indeed, the analysis of Mitotracker intensity showed that
resveratrol induced an increase in mitochondrial mass
compared to non-treated cells (Figure 1A). Equol alone
was not effective in terms of augmenting the mitochondrial
mass, however the combined treatment (resveratrol +
equol) was more effective respect to resveratrol alone
(Figure 1A). It is important to point out that mitochondrial
dysfunction tend to induce a wide range of adaptations of
nuclear gene expression, named the retrograde response
[21]. Typical of this adaptive process (mitohormesis)
[22-24] is the up-regulation of mitochondrial biogen-
esis [25]. A robust adaptive response may further ex-
plain the increase in mitochondrial mass.
The enhanced mitochondrial biogenesis in cells treated
with both compounds simultaneously was also confirmed
by the increased cellular mtDNA content (Figure 1B).
Overall, we found that co-treatment with resveratrol and
equol positively affect mitochondrial biogenesis.
Induction of SIRT1 by the association of resveratrol and
equol
It has been consistently demonstrated that activation of
SIRT1 stimulates mitochondrial biogenesis and resveratrol
has been utilized as a SIRT1 activator to regulate mito-
chondrial function [26]. Since equol exhibits a wide range
of biological properties, it may be a sirtuin-targeting nutra-
ceutical to prevent mitochondrial decline. Analysis of the
effect of a combined administration of resveratrol and
equol showed an increase in SIRT1 enzymatic activity in
HUVEC endothelial cells (Figure 2). Although equol was
much less effective to induce SIRT1, the effect of a com-
bination of resveratrol and equol was greater than the re-
sponse achieved by the single compounds (Figure 2).
Therefore, the combination of resveratrol with equol is
also associated with the activation of SIRT1.
The association of resveratrol and equol activates
mitochondrial biogenesis factor
PGC1-α is a key component in modulating mitochondrial
function and interacts with transcription factors such as
NRF-1and TFAM. Specifically, PGC1-α is involved in regu-
lating the expression of mtDNA via increased expression
of TFAM which is co-activated by NRF-1 [27]. Moreover,
NRF-1 in addition to regulating the activation of TFAM is
also a downstream effector of SIRT1/PGC1-α [28]. Ac-
cordingly we used qRT-PCR measurements to analyse the
expression of PGC1-α, NRF-1and TFAM. The results indi-
cate that these mitochondrial biogenesis factors were
strongly increased by combined treatment of resveratrol
and equol (Figure 3).Conclusions
Collectively, these data demonstrate that the combination
of two known natural products, resveratrol and equol ex-
erts a synergistic effect on mitochondrial function because
stimulates the mitochondrial biogenesis more than the
single compounds alone. Clearly, more work is needed to
provide novel insights into the mechanisms by which res-
veratrol and equol synergize to regulate the mitochondrial
dynamics. However, the co-administration of these agents
may be a possible nutraceutical and/or anti-ageing strat-
egy for a number of mitochondria-associated disorders.
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